Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis
Renal Artery Obstruction, Kidney Failure
About this trial
This is an interventional treatment trial for Renal Artery Obstruction focused on measuring Renal artery stenosis, Stent, Renal failure, Atorvastatin, Hypertension, Atherosclerosis
Eligibility Criteria
Inclusion Criteria: Age >18 years Ostial atherosclerotic renal artery stenosis ≥50% on CTA, MRA or intra-arterial angiography Estimated creatinine clearance <80 ml/min/1.73m2 according to the Cockcroft and Gault formula, on two occasions within one month Exclusion Criteria: Declined informed consent Proven cholesterol embolisation at previous interventions Renal artery diameter <4mm Estimated creatinine-clearance <15ml/min/1.73m2 Diabetes Mellitus with proteinuria >3g/24h Any known cause of renal failure other than ischemic nephropathy Pulmonary oedema in the presence of bilateral renovascular disease in combination with intolerance of ACE-inhibitors/ Angiotensin-II antagonists defined as a fall of estimated creatinine clearance of >20% Malignant hypertension (fundus grade III/IV) Myocardial infarction or CVA <3 months before planned date of inclusion Contra-indication for the use of atorvastatin
Sites / Locations
- UMC Utrecht